WealthPlan Investment Management’s West Pharmaceutical WST Stock Holding History

WealthPlan Investment Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$231K	Buy	+643	New	+$197K	0.01%	438

Other funds holding WST

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Asset Management One

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Ninety One (UK)

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

WealthPlan Investment Management's WST Position: Q2 2026 in Review

WealthPlan Investment Management opened a new position in West Pharmaceutical (WST) in Q2 2026: 643 shares worth $231K. The stake represents 0.01% of the portfolio and ranks #438 among its holdings.

240 funds tracked by Wall St. Rank hold WST as of Q2 2026.

WealthPlan Investment Management held 643 shares of West Pharmaceutical worth $231K as of Q2 2026.
West Pharmaceutical was a new WealthPlan Investment Management position in Q2 2026.
West Pharmaceutical made up 0.01% of WealthPlan Investment Management's portfolio in Q2 2026, its #438 holding.
240 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on WealthPlan Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.